Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dezhou Haizhi Pharmaceutical is a China-based company specializing in the research, development, and large-scale production of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Located in the Dezhou Economic and Technological Development Zone, the company operates as a contract manufacturer (CMO/CDMO) serving the global life sciences industry. Their product portfolio primarily focuses on complex organic synthesis, including intermediates for antiviral, cardiovascular, and anti-tumor medications. The company maintains modern manufacturing facilities and R&D laboratories to support custom synthesis projects from lab scale to commercial production. It is recognized for its expertise in high-pressure hydrogenation and other specialized chemical processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dezhou Haizhi Pharma.